Abstract:The limited distribution of anticancer nanodrugs remains a bottle-neck for their therapeutic effect. Several strategies, such as surface modification, photothermal activation, and microenvironment modulation, have been studied to improve the penetration of anticancer drugs in solid tumours. However, the inherent high osmotic pressure, high cell density, lack of blood supply, and other biological barriers in solid tumors make it difficult for nanomedicine to infiltrate in the tumors, thus inaccessible to the distal cells to exert an effective therapeutic effect. Therefore, the way to deliver sufficient drugs to infiltrate in a tumour is a key problem that should be solved quickly. Herein, we constructed a molecularly precise polylysine-dendrimer-drug conjugate with gamma-glutamyl transpeptidase (GGT)-sensitive termini and obtained a zwitterionic gamma-glutamyl functionalized dendrimer-drug conjugate, i.e., G4/CPT-BGA. The results showed the molecular weight of G4/CPT-BGA dendrimer was 20 kDa with a small size of 5 nm and a moderate surface charge of 2 mV. The G4/CPT-BGA could undergo rapid GGT-triggered charge-reversal from zwitterionic to cationic, thereby quickly endocytosed by tumor cells, releasing the conjugated drug (CPT) to exert effective cytotoxicity. The in vitro endocytosis and exocytosis experiments showed that G4/CPT-BGA was able to traffic in cells through a caveolae-mediated pathway, then traffic out of cells via Golgi-apparatus, thus achieving active transcytosis for transcellular delivery. The tumor penetration ability of G4/CPT-BGA was investigated using three-dimensional multicellular spheroids, which showed G4/CPT-BGA could evenly distribute throughout the spheroids via transcytosis-mediated active tumour infiltration. Therefore, a simple modification of the cationic dendrimer with GGT responsive zwitterionic gamma-glutamine enables the dendrimer to actively transcytosis across cells, thereby avoiding the paracellular diffusion obstacles, which may also be applicable for designing anticancer nanomedicine systems with enhanced penetration ability.

Targeting Cancer Cells with Biotin–dendrimer Conjugates

The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.

Research Status of Dendrimer Micelles in Tumor Therapy for Drug Delivery

Aptamer-conjugated dendrimer-modified quantum dots for cancer cell targeting and imaging

Dye-cored polylysine dendrimer as luminescent nanoplatform for imaging-guided anticancer drug delivery

Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.

Dendrimer functionalized water soluble magnetic iron oxide conjugates as dual imaging probe for tumor targeting and drug delivery

Recent advances in multifunctional dendrimer-based complexes for cancer treatment

Interaction of Dendrimers with the Immune System: an Insight into Cancer Nanotheranostics

Aptamer-Conjugated Dendrimer-Modified Quantum Dots For Glioblastoma Cells Imaging

Arginine-Glycine-Aspartic Acid-Conjugated Dendrimer-Modified Quantum Dots For Targeting And Imaging Melanoma

Enzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic Tumors

Biotin-Tagged Polysaccharide Vesicular Nanocarriers for Receptor-Mediated Anticancer Drug Delivery in Cancer Cells

Evaluation of <i>in Vitro</i> Tumor Penetration Behavior of Enzyme-responsive Dendrimer-drug Conjugate

Dendrimers for Cancer Immunotherapy: Avidity‐based Drug Delivery Vehicles for Effective Anti‐tumor Immune Response

Magnetically and Ph Dual Responsive Dendrosomes for Tumor Accumulation Enhanced Folate-Targeted Hybrid Drug Delivery.

The Importance of Biotinylation for the Suitability of Cationic and Neutral Fourth-Generation Polyamidoamine Dendrimers as Targeted Drug Carriers in the Therapy of Glioma and Liver Cancer

Peptide-conjugated PEGylated PAMAM as a highly affinitive nanocarrier towards HER2-overexpressing cancer cells

Dendrimer-based Nanohybrids in Cancer Photomedicine

A Transformable Amphiphilic and Block Polymer−Dendron Conjugate for Enhanced Tumor Penetration and Retention with Cellular Homeostasis Perturbation via Membrane Flow

Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy